jueves, 6 de febrero de 2025

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

https://www.news-medical.net/news/20250206/SAB-BIO-announces-positive-topline-Phase-1-clinical-results-with-potentially-disease-modifying-T1D-therapy-SAB-142.aspx

No hay comentarios:

Publicar un comentario